12 abstracts found.



Patterns of IMRT delivery in England in 2014

Year:

Session type:

Theme: ,

john staffurth1,4,gerry hanna3,chris ball2,tracey ellison2

1cardiff university, cardiff, UK,2clatterbridge Cancer Centre, liverpool, UK,3queens university belfast, belfast, UK,4velindre cancer centre, cardiff, UK


Characterisation of tumour boost with diffusion weighted MRI (DW-MRI) to inform biological target volume for radical radiotherapy in muscle invasive bladder cancer (MIBC)

Year:

Session type:

Theme: ,

Shaista Hafeez1,2,Mu Koh1,2,Dualta McQuaid1,2,Aslam Sohaib2,Robert Huddart1,2

1The Institute of Cancer Research, London, UK,2The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK


A Method of Unwrapping 3D Complex Hollow Organs for Spatial Dose Surface Analysis

Year:

Session type:

Theme: ,

Alon Witztum1,Samantha Warren1,Mike Partridge1,Maria Hawkins1

1CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK


Adjuvant radiation therapy of soft-tissue sarcoma achieves good results in elderly patients: The RMH experience, aged 80-94 years,1991-2014.

Year:

Session type:

Theme: ,

Shane Zaidi1,Nidhin Raj1,Alison Dunlop1,Rolyn Alvarado1,Cerys Propert-Lewis1,Ian Judson1,Robin L Jones1,Charlotte Benson1,Sam Hackett1,Komel Khabra1,Omar Al-Muderis1,Christina Messiou1,Myles Smith1,Eleanor Moskovic1,Khin Thway1,Cyril Fisher1,Dirk Strauss1,Andrew Hayes1,Meirion Thomas1,Aisha Miah1

1The Royal Marsden NHS Foundation Trust, London, UK


Development of Radiolabelled Drug Carrier Systems for Molecularly Targeted Radiotherapy

Year:

Session type:

Theme: ,

Jyothi Menon1,Joshua Owen1,Robert Carlisle1,Katherine Vallis1

1University of Oxford, Oxford, UK


Refining proximal gastrointestinal tract radiotherapy tolerance parameters using published clinical data

Year:

Session type:

Theme: ,

Daniel Holyoake1,Mike Partridge1,Maria Hawkins1

1Department of Oncology, University of Oxford, Oxford, UK


Accumulated dose to the rectum, calculated from auto-contoured image guidance CT scans, is lower than planned dose in the majority of patients treated radiotherapy for prostate cancer

Year:

Session type:

Theme: ,

Jessica Scaife1,2,Simon Thomas1,3,Karl Harrison1,4,Amy Bates1,2,Julia Forman1,6,Michael Sutcliffe1,5,Marina Romanchikova1,3,Raj Jena1,2,M Andy Parker1,4,Neil Burnet1,2

1Cancer Research UK VoxTox Research Group, University of Cambridge, Cambridge, UK,2University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke’s Hospital, Cambridge, UK,3Medical Physics Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK,4University of Cambridge Department of Physics, Cavendish Laboratory, Cambridge, UK,5University of Cambridge Department of Engineering, Cambridge, UK,6Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK


Differential PTEN expression influences the radio-response of prostate cancer cell lines exposed to high-dose per fraction radiotherapy.

Year:

Session type:

Theme: ,

Dominique French1,Karl T. Butterworth1,Kevin M Prise1,Suneil Jain1,2

1Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, QueenÂ’s University Belfast, Belfast, UK,2Northern Ireland Cancer Centre, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, UK


Modern pelvic chemoradiotherapy techniques continue to affect the small bowel

Year:

Session type:

Theme: ,

Katherine White1,Caroline Henson2,Sorrel Burden3,Simon Lal2,Susan Davidson1,John McLaughlin3

1The Christie NHS Foundation Trust, Manchester, UK,2Salford Royal NHS Foundation Trust, Manchester, UK,3University of Manchester, Manchester, UK


Demonstrating an Effective Model of Patient and Public Involvement in Cancer Research

Year:

Session type:

Theme: ,

Ellen Donovan1,2,Sophie Gasson2,David Chuter2,Robert Flavel2,Maggie Wilcox2,Helen-Teresa Edwards2

1Royal Marsden NHS Foundation Trust/Institute of Cancer Research, London, UK,2KSS Local Research Network, Kent, Surrey and Sussex, UK


Patients’ views on the role of music in the radiotherapy department.

Year:

Session type:

Theme: ,

Alison Stillie1,Catriona Baker2,Michael Blayney2,Matilda Coke2,Morven Davies2,Christina Fairley2,Katie Feather2,Rebecca Finch2

1Edinburgh Cancer Centre, Edinburgh, UK,2University of Edinburgh Medical School, Edinburgh, UK


Oligometastases: Is the line between radical and palliative Radiotherapy starting to blur?

Year:

Session type:

Theme: ,

Liam Mannion1,Shyam Parmar1

1Bupa Cromwell Hospital, London, UK